Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-235-0 | CAS number: 931-40-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- Not stated
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted prior to test guidelines and GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 962
- Report date:
- 1962
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Test material was administered in the diet at 5 and 20% for 90 days. Body weights and feed consumption were measured at selected intervals. At necropsy, lung, heart, liver, kidney, spleen and testes absolute and relative weights were obtained. Basic hematologic and clinical chemistry measurements were made.
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- Glycerol
- EC Number:
- 200-289-5
- EC Name:
- Glycerol
- Cas Number:
- 56-81-5
- Molecular formula:
- C3H8O3
- IUPAC Name:
- propan-1,2,3-triol
- Details on test material:
- Test material obtained from Dow Chemical, Shell and Proctor and Gamble was used. This study was conducted to determine whether there was a difference in the toxicologic profile of the three products. No additional information provided.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- After weaning at 21 days, the rats were maintained on Purina Laboratory Chow pellets until the age of 52 days, when they were divided according to body weight into well matched groups of each sex and started on the experimental diets. The stock diet for this experiment was ground Purina Laboratory Chow. Two rats were housed together in a wire bottom cage. Food and water were available at all times
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- not specified
- Analytical verification of doses or concentrations:
- no
- Details on analytical verification of doses or concentrations:
- No analytical verification of concentration provided.
- Duration of treatment / exposure:
- 90 days
- Frequency of treatment:
- Daily
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 5 and 20 %
Basis:
nominal in diet
- No. of animals per sex per dose:
- 10 males + 10 females per dose level
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- Groups of male and female rats (ten of each sex per group) were maintained for :90 days on diets containing 0.0 (Control), 20 percent and 5 percent Proctor and Gamble glycerine 20 percent and 5 percent Shell glycerine, and 20 percent and 5 percent Dow glycerine.
During the course of the experiment, the animals were weighed twice weekly for the first 28 days, and once a week thereafter. They were observed frequently for gross changes in appearance or behavior. Whenever possible, failing animals were autopsied when moribund in an effort to ascertain the cause of impending death. In addition, records were kept of mortality, and food consumption was. recorded for the first month.
Terminal hematological values were obtained from five female rats at the 0.0 (Control), 20, and 5 percent level of each of the three brands. At autopsy the animals were fasted overnight, weighed, and killed by decapitation. The lungs, heart, liver, kidneys, spleen, brain and testes were removed and weighed. Portions of these organs, as well as pancreas and adrenals, were preserved and hematoxylin/eosin stained sections were prepared for histological examination.
Samples of blood serum were obtained for the determination of urea nitrogen content and alkaline-phosphatase activity. - Positive control:
- No data.
Examinations
- Observations and examinations performed and frequency:
- During the course of the experiment, the animals were weighed twice weekly for the first 28 days, and once a week thereafter. They were observed frequently for gross changes in appearance or behavior. Whenever possible, failing animals were autopsied when moribund in an effort to ascertain the cause of impending death. In addition, records were kept of mortality, and food consumption was. recorded for the first month.
- Sacrifice and pathology:
- Terminal hematological values were obtained from five female rats at the 0.0 (Control), 20, and 5 percent level of each of the three brands. At autopsy the animals were fasted overnight, weighed, and killed by decapitation. The lungs, heart, liver, kidneys, spleen, brain and testes were removed and weighed. Portions of these organs, as well as pancreas and adrenals, were preserved and hematoxylin/eosin stained sections were prepared for histological examination.
Samples of blood serum were obtained for the determination of urea nitrogen content and alkaline-phosphatase activity. - Other examinations:
- No additional information available.
- Statistics:
- When appropriate, the Fisher "t" t e s t was used in comparing the mean values obtained on the experimental groups with those of the controls; in general, probability values (p) of less than 0.05 were interpreted as indicating a significant difference.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- gained weight faster than controls
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- increased liver/body weight ratio
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- liver histopathology
- Histopathological findings: neoplastic:
- not specified
- Details on results:
- 5 percent level
No evidence of adverse effect was noted in male or female rats when maintained for 90 days on diets containing 5 percent glycerine, whether produced by Proctor and Gamble, Shell, or Dow. Judgment was based on gross appearance and behavior, mortality, growth, food consumption records, final average body and organ weights, terminal hematological values, blood urea nitrogen and alkaline phosphatase determinations, and gross and microscopic examination of the tissues.
20 .percent level
In the male rats which received 20 percent Proctor and Gamble, Shell, or Dow glycerine, there was an increase in the final liver/body weight ratio, and upon microscopic examination generalized cloudy swelling and hypertrophy of the parenchymal cells was observed. The only effect in the female rats on this level was some generalized cloudy swelling upon microscopic examination of the liver. There was no significant variation of the extent of liver changes in the rats fed the three brands of glycerine as a part of the diet.
The statistically significant decrease in the final heart/body weight ratio in the female rats fed 20 percent Shell glycerine, and the increase in the final kidney/body weight ratio in the female rats fed 20 percent Dow glycerine, were not accompanied by any cellular changes, nor is significance indicated by examination of the absolute weights in grams. Therefore, these may be attributed to chance.
In general, all the groups of rats that received the experimental diets containing glycerine grew faster and bigger than the controls.
Effect levels
open allclose all
- Dose descriptor:
- NOEL
- Effect level:
- 50 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No treatment related effects noted.
- Dose descriptor:
- LOEL
- Effect level:
- 200 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Average body weight for male and female rats after 4 weeks was approximately 240 and 155 g, respectively. Average feed consumption for the first 30 days for male and female rats was 22 and 20 g/day, respectively. Using these values, a 5% glycerol in the diet corresponds to 4580 and 6450 mg/kg/day for male and female rats, respectively. At 20% glycerol in the diet, male and female rats ingested 18,750 and 25,800 mg/kg/day, respectively. Obviously younger animals ingested more glycerol in the diet while older animals would ingest less glycerol in the diet. But this gives an approximation of the dose these animals received.
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of the study, the dietary level of 5 percent was tolerated without any evidence of adverse effect, while in the dose level of 20 percent, the only signs of adverse effects were slight pathological changes in the liver.
- Executive summary:
The effect of glycerine following administration for 90 days in a subchronic toxicity study was examined.
Rats fed 5 or 20% glycerine in the diet for 90 days gained weight at a faster rate than control animals. There were no adverse treatment related effects noted in male or female rats fed 5% glycerine in the diet.
In the male rats which received 20 percent glycerine, there was an increase in the final liver/body weight ratio and upon microscopic examination generalized cloudy swelling and hypertrophy of the parenchymal cells was observed. The only effect in the female rats on this level was some generalized cloudy selling upon microscopic examination of the liver.
A 5% glycerol in the diet corresponded to 4580 and 6450 mg/kg/day for male and female rats, respectively, after 4 weeks and a 20% glycerol in the diet corresponded to 18,750 and 25,800 mg/kg/day for male and female rats, respectively, after 4 weeks.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.